Skip to main content
Bonesupport Holding logo

Bonesupport Holding — Investor Relations & Filings

Ticker · BONEX ISIN · SE0009858152 LEI · 549300COLY053IGTLD63 ST Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2020-04-14 Regulatory Filings
Country SE Sweden
Listing ST BONEX

About Bonesupport Holding

https://www.bonesupport.com/en-eu/

Bonesupport Holding is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes. Its core product platform, CERAMENT®, is an innovative range of osteoconductive and drug-eluting products designed to heal bone defects. A key characteristic of CERAMENT® is its ability to remodel into the patient's own host bone, typically within six to twelve months. The products are used to treat bone voids and defects arising from trauma, infection, disease, or related surgical procedures. The radiopaque nature of the material allows for visualization during and after surgery.

Recent filings

Filing Released Lang Actions
BONESUPPORT announces CERAMENT in combination with bisphosphonate shows promising results in preclinical long-term study
Regulatory Filings Classification · 1% confidence The document is explicitly titled '# Press Release' and announces new preclinical data supporting the development of a combination product. It provides key highlights (promising results, citation of a published study) and contact information for investor relations and press. It is not a comprehensive financial report (like 10-K or IR), nor is it a transcript (CT) or a formal regulatory filing detailing insider trades (DIRS) or capital changes (CAP/SHA). Since it is an announcement of new information/data, and it doesn't fit the specific categories like ER (Earnings Release) or DIV (Dividend Notice), it falls best under the general category for regulatory/corporate announcements that aren't otherwise specified, which is Regulatory Filings (RNS). Given the short length and nature as an announcement, RNS is the most appropriate fit among the available options for non-financial, non-meeting related corporate news.
2020-04-14 English
Annual Report 2019
Annual Report Classification · 1% confidence The document is a comprehensive annual report for BONESUPPORT for the year 2019. It includes a table of contents, CEO statement, financial results, management report (förvaltningsberättelse), and notes. It is clearly the full annual report rather than an announcement or a summary, as it contains detailed financial data and operational reviews. FY 2019
2020-04-03 Swedish
Annual Report 2019
Annual Report Classification · 1% confidence The document is a comprehensive annual report for BONESUPPORT for the fiscal year 2019. It contains a 'Message from the CEO', 'Directors' report', 'Financial reports 2019', 'Auditor's report', and 'Corporate governance report'. It is clearly the full annual report rather than an announcement or a summary, as it includes detailed financial statements, notes, and management commentary. FY 2019
2020-04-03 English
Ändring av antalet aktier och röster i BONESUPPORT HOLDING AB (publ)
Share Issue/Capital Change Classification · 1% confidence The document is a press release from BONESUPPORT HOLDING AB dated March 31, 2020, announcing a change in the total number of shares and votes due to a directed share issue, the repurchase of C-shares, and the exercise of warrants. This directly relates to changes in the company's capital structure and share count. This aligns best with the 'Share Issue/Capital Change' definition (Code: SHA). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). The document explicitly details the resulting share count and voting rights after capital movements.
2020-03-31 Swedish
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
Share Issue/Capital Change Classification · 1% confidence The document explicitly announces a 'Change in number of shares and votes' due to a direct share issue, repurchase of series C shares, and exercise of warrants. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not an earnings release, an annual report, or a director's dealing, but a specific notification about the total outstanding shares and voting rights.
2020-03-31 English
Accelererad väg till marknadsgodkännande för CERAMENT[®] G i USA – BONESUPPORT[TM] lämnar in De Novo-ansökan
Regulatory Filings Classification · 1% confidence The document is a press release dated March 23, 2020, announcing that BONESUPPORT will submit a De Novo application to the US FDA for its product CERAMENT G. It details regulatory strategy, product potential, and includes contact information and a notice for a conference call. This type of announcement, detailing regulatory steps, strategic updates, and financial/product news outside of standard periodic reports (like 10-K or IR), fits best under a general regulatory announcement or news release category. Since it is a formal announcement of a significant corporate/regulatory event, and not a transcript (CT), earnings release (ER), or a specific financial filing form, it aligns most closely with a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the focus was purely on fundraising, but here the focus is on regulatory submission strategy. Given the context of announcing a major regulatory submission (De Novo application) and scheduling a conference call, RNS (Regulatory Filings - general regulatory announcements/fallback) is the most appropriate classification for this type of corporate news release.
2020-03-23 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.